Skip to content

Observational Study for Tumor Neonatal Antigen

Observational Study for Tumor Neonatal Antigen

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028146
Enrollment
Unknown
Registered
2019-12-13
Start date
2019-12-15
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Case series:N/A

Sponsors

Quanzhou First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with solid tumors, regardless of gender, aged 18 to 80 years. 2. According to routine diagnostic procedures, confirm that the tumor is surgically removed. 3. Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Active infection with bacterial or fungal infection; 2. Patients with HIV infection, HCV infection, serious coronary artery disease or asthma, serious cerebrovascular disease or other diseases that the researchers think can not be entered into the group; 3. Drug abuse, clinical or psychological or social factors which will influence the informed consent or the study implementation; 4. influence the safety or compliance of the patients.

Design outcomes

Primary

MeasureTime frame
WES;RNA sequence;

Countries

CHINA

Contacts

Public ContactYibin Su

Quanzhou First Hospital

qzsyb@sina.com+86 18126874288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026